For dulaglutide, an increased rate of exposure was also observed among RA cases (0.75%) compared to controls (0.55%), although this difference did not reach statistical significance (OR 1.36, 95% CI 0.90–2.01; p = 0.110).
← all excerpts
The association between glucagon-like peptide-1 receptor agonist and rheumatoid arthritis: a population-based case-control study.
1
0.1100
0.1100